Early response and remission as predictors of a good outcome of a major depressive episode at 12-month follow-up: A prospective, longitudinal, observational study

Journal of Clinical Psychiatry

Volumn 73, Issue 2, 2012, Pages 185-191

  Ciudad, Antonio ^a   Álvarez, Enrique ^b   Roca, Miquel ^c   Baca, Enrique ^d   Caballero, Luis ^d   García De Polavieja, Pepa ^a   Casillas, Marta ^a   Valladares, Amparo ^a   Gilaberte, Inmaculada ^a  

^a ELI LILLY AND COMPANY   (Spain)

^b HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^c Hospital Joan March   (Spain)

^d HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; DULOXETINE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ADULT; ARTICLE; CLINICAL GLOBAL IMPRESSION SCALE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG EFFICACY; FEMALE; FOLLOW UP; HAMILTON SCALE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; OUTPATIENT; POST HOC ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; QUALITY OF LIFE; REMISSION; TREATMENT DURATION; TREATMENT RESPONSE;

EID: 84857722781     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.10m06314     Document Type: Article

References (40)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. Washington, DC: American Psychiatric Publishing; 2000.
2. Tadić A, Helmreich I, Mergl R, et al. Early improvement is a predictor of treatment outcome in patients with mild major, minor or subsyndromal depression. J Affect Disord. 2010;120(1-3):86-93. doi:10.1016/j.jad.209.04.014 PubMed
3. Wade AG, Schlaepfer TE, Andersen HF, et al. Clinical milestones predict symptom remission over 6-month and choice of treatment of patients with major depressive disorder (MDD). J Psychiatr Res. 2009;43(5): 568-575. doi:10.1016/j.jpsychires.208.09.08 PubMed
4. Papakostas GI, Petersen T, Denninger JW, et al. Psychosocial functioning during the treatment of major depressive disorder with fluoxetine. J Clin Psychopharmacol. 2004;24(5):507-511. doi:10.1097/01.jcp.0138761.85363.d5 PubMed (Pubitemid 39274204)
5. Kelsey JE. Clinician perspective on achieving and maintaining remission in depression. J Clin Psychiatry. 2001;62(suppl 26):16-21. PubMed (Pubitemid 34003370)
6. Mulder RT, Frampton CM, Luty SE, et al. Eighteen months of drug treatment for depression: predicting relapse and recovery. J Affect Disord. 2009;114(1-3):263-270. doi:10.1016/j.jad.208.08.02 PubMed
7. Paykel ES, Ramana R, Cooper Z, et al. Residual symptoms after partial remission: an important outcome in depression. Psychol Med. 1995;25(6):1171- 1180. doi:10.1017/S03291703146 PubMed
8. Pintor L, Torres X, Navarro V, et al. Is the type of remission after a major depressive episode an important risk factor to relapses in a 4-year follow up? J Affect Disord. 2004;82(2):291-296. doi:10.1016/j.jad.203.1.08 PubMed (Pubitemid 39370832)
9. Judd LL, Akiskal HS, Maser JD, et al. Major depressive disorder: a prospective study of residual subthreshold depressive symptoms as predictor of rapid relapse. J Affect Disord. 1998;50(2-3):97-108. doi:10.1016/S0165-0327(98) 0138-4 PubMed (Pubitemid 28551779)
10. Prien RF, Kupfer DJ. Continuation drug therapy for major depressive episodes: how long should it be maintained? Am J Psychiatry. 1986;143(1):18-23. PubMed (Pubitemid 16185856)
11. Szádóczky E, Rózsa S, Zámbori J, et al. Predictors for 2-year outcome of major depressive episode. J Affect Disord. 2004;83(1):49-57. doi:10.1016/j.jad.204.05.01 PubMed (Pubitemid 39488389)
12. Goldberg JF, Harrow M. Consistency of remission and outcome in bipolar and unipolar mood disorders: a 10-year prospective follow-up. J Affect Disord. 2004;81(2):123-131. doi:10.1016/S0165-0327(03)0161-7 PubMed (Pubitemid 39070085)
13. Mulder RT, Joyce PR, Frampton CM, et al. Six months of treatment for depression: outcome and predictors of the course of illness. Am J Psychiatry. 2006;163(1):95-100. doi:10.176/api.ajp.163.1.95 PubMed (Pubitemid 43050109)
14. Thase ME. Achieving remission and managing relapse in depression. J Clin Psychiatry. 2003;64(suppl 18):3-7 PubMed.
15. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23(1):56-62. doi:10.136/jnp.23.1.56 PubMed
16. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol. 1967;6(4):278-296. PubMed
17. Guy W. ECDEU Assessment Manual for Psychopharmacology. US Dept Health, Education, & Welfare publication (ADM) 76-338. Rockville, MD: National Institute of Mental Health; 1976:218-222.
18. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychiatry. 1959;32(1):50-55.
19. Riskind JH, Beck AT, Brown G, et al. Taking the measure of anxiety and depression: validity of the reconstructed Hamilton scales. J Nerv Ment Dis. 1987;175(8):474-479. doi:10.1097/05053-1987080-05 PubMed (Pubitemid 17127942)
20. DeLoach LJ, Higgins MS, Caplan AB, et al. The visual analog scale in the immediate postoperative period: intrasubject variability and correlation with a numeric scale. Anesth Analg. 1998;86(1):102-106. doi:10.1097/0539-198010-020 PubMed (Pubitemid 28040099)
21. First MB, Spitzer RL, Gibbon M, et al. Structured Clinical Interview for DSM-IV Axis II Personality Disorders (SCID-II), version 2.0. New York, NY: New York State Psychiatric Institute, Biometrics Research Department; 1994.
22. Maffei C, Fossati A, Agostoni I, et al. Interrater reliability and internal consistency of the structured clinical interview for DSM-IV Axis II personality disorders (SCID-II), version 2.0. J Pers Disord. 1997;11(3):279-284. PubMed (Pubitemid 27478022)
23. Goldman HH, Skodol AE, Lave TR. Revising Axis V for DSM-IV: a review of measures of social functioning. Am J Psychiatry. 1992;149(9): 1148-1156. PubMed
24. [No authors listed]. EuroQol - a new facility for the measurement of health-related quality of life. The EuroQol Group. Health Policy. 1990; 16(3):199-208. doi:10.1016/0168-8510(90)90421-9 PubMed
25. Sobocki P, Ekman M, Agren H, et al. Health-related quality of life measured with EQ-5D in patients treated for depression in primary care. Value Health. 2007;10(2):153-160. doi:10.1/j.1524-473.206.0162.x PubMed (Pubitemid 46481142)
26. Lee J. An insight on the use of multiple logistic regression analysis to estimate association between risk factor and disease occurrence. Int J Epidemiol. 1986;15(1):22-29. doi:10.1093/ije/15.1.2 PubMed (Pubitemid 16130917)
27. Hosmer DW, Lemeshow S. A goodness-of-fit test for the multiple logistic regression model. Commun Stat Theory Methods. 1980;9(10): 1043-1069.
28. van Calker D, Zobel I, Dykierek P, et al. Time course of response to antidepressants: predictive value of early improvement and effect of additional psychotherapy. J Affect Disord. 2009;114(1-3):243-253. doi:10.1016/j.jad.208.07. 023 PubMed
29. Henkel V, Seemüller F, Obermeier M, et al. Does early improvement triggered by antidepressants predict response/remission? analysis of data from a naturalistic study on a large sample of inpatients with major depression. J Affect Disord. 2009;115(3):439-449. doi:10.1016/j.jad.208.10.01 PubMed
30. Nakajima S, Suzuki T, Watanabe K, et al. Accelerating response to antidepressant treatment in depression: a review and clinical suggestions. Prog Neuropsychopharmacol Biol Psychiatry. 2010;34(2):259-264. doi:10.1016/j.pnpbp. 209.12.01 PubMed
31. Lutz W, Stulz N, Köck K. Patterns of early change and their relationship to outcome and follow-up among patients with major depressive disorders. J Affect Disord. 2009;118(1-3):60-68. doi:10.1016/j.jad.209.01.019 PubMed
32. Szegedi A, Jansen WT, van Willigenburg AP, et al. Early improvement in the first 2 weeks as a predictor of treatment outcome in patients with major depressive disorder: a meta-analysis including 6562 patients. J Clin Psychiatry. 2009;70(3):344-353. doi:10.408/JCP.07m03780 PubMed
33. Dawson MY, Michalak EE, Waraich P, et al. Is remission of depressive symptoms in primary care a realistic goal? a meta-analysis. BMC Fam Pract. 2004;5:19. doi:10.186/1471-296-5-19
34. Holma KM, Holma IA, Melartin TK, et al. Long-term outcome of major depressive disorder in psychiatric patients is variable. J Clin Psychiatry. 2008;69(2):196-205. doi:10.408/JCP.v69n0205 PubMed (Pubitemid 351469262)
35. Pettit JW, Lewinsohn PM, Roberts RE, et al. The long-term course of depression: development of an empirical index and identification of early adult outcomes. Psychol Med. 2009;39(3):403-412. doi:10.1017/S0329170803851 PubMed
36. World Health Orgnization. Constitution. Geneva, Switzerland; 1946. http://apps.who.int/gb/bd/PDF/bd47/EN/constitution-en.pdf.
37. Trivedi MH. Tools and strategies for ongoing assessment of depression: a measurement-based approach to remission. J Clin Psychiatry. 2009;70(suppl 6):26-31. doi:10.408/JCP.813su1c.04 PubMed
38. Romera I, Perez V, Menchón JM, et al. Social and occupational functioning impairment in patients in partial versus complete remission of a major depressive disorder episode: a six-month prospective epidemiological study. Eur Psychiatry. 2010;25(1):58-65. doi:10.1016/j.eurpsy.209.02.07 PubMed
39. Furukawa TA, Takeuchi H, Hiroe T, et al. Symptomatic recovery and social functioning in major depression. Acta Psychiatr Scand. 2001;103(4):257-261. doi:10.1034/j.160-047.201.0140.x PubMed (Pubitemid 32304270)
40. American Psychiatric Association APA. (2004). Treating major depressive disorder: a quick reference guide. http://www.psychiatryonline.com/pracGuide/ PracticePDFs/MDD2e-QRG.pdf.